Revenue trend & guidance
Perimeter Medical Imaging AI disclosed that Q2‑2025 revenue rose sharply year‑over‑year, climbing roughly 200 % to about $6.8 million versus $2.3 million in Q2‑2024. The acceleration was powered by the commercialization of its AI‑assisted imaging platform in several U.S. and Canadian hospital networks, with a +30 % month‑over‑month increase in new subscription contracts during the quarter. Management reiterated its forward‑looking outlook, guiding Q3‑2025 revenue of $7.5‑$8.2 million (≈10‑20 % sequential growth) and targeting full‑year 2025 revenue of $30‑$32 million, which would represent a ~250 % increase versus FY‑2024. The guidance rests on the rollout of two new AI modules slated for Q4 and on an expanding partner pipeline that the company expects to convert into at least five additional enterprise contracts in the next six months.
Trading implications
The top‑line trajectory and above‑market guidance have already turned the stock’s sentiment sharply positive (sentiment score 5). On the technical side, PYNKF has broken above its 50‑day EMA (~$0.48) and is now trading near the upper edge of a descending‑channel pattern, with volume up ≈60 % versus the prior 20 sessions—signals that bullish momentum may be gaining steam. However, the micro‑cap nature of the stock implies a thin order book; a short‑term pullback to the $0.55‑$0.58 support zone could trigger a bounce back to the $0.70‑$0.75 breakout level if the Q3 guidance proves credible. Actionable take‑away: consider a long position at current levels with a stop‑loss around $0.55 and a price target near $0.85 (the top of the channel) contingent on a confirming earnings beat or a positive update on the new AI modules. Conversely, if Q3 revenue comes in below the $7.5 million low end of guidance, the stock could face a swift reversal, making a short‑cover or defensive hedge prudent.